Inhibrx Biosciences Inc. held its Annual Meeting of Stockholders on May 28, 2025, in a virtual format. During the meeting, Jon Faiz Kayyem, Ph.D., and Kristiina Vuori, M.D., Ph.D., were elected as Class I Directors. Additionally, the selection of BDO USA, P.C. as the independent registered public accounting firm for the year ending December 31, 2025, was ratified. Both proposals were approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inhibrx Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002007919-25-000063), on May 28, 2025, and is solely responsible for the information contained therein.